← Eichor
Condition: Irritable Bowel Syndrome Diarrhoea Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Irritable Bowel Syndrome Diarrhoea

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Effect of Ebastine in Patients With Diarrhea Predominant Irritable Bowel Syndrome
Phase 2/Phase 3 · 1 location(s) · Md. Hazrat Ali · NCT07114055Saccharomyces Boulardii CNCM I-745 in Irritable Bowel Syndrome
Phase 3 · 10 location(s) · Biocodex · NCT07168434Study on the Effectiveness and Mechanism of Tong-Xie-Yao-Fang in Treating Diarrhea-predominant Irritable Bowel Syndrome
Phase 1 · 1 location(s) · Xiyuan Hospital of China Academy of Chinese Medical Sciences · NCT06737666B.Subtilis Attenuate Symptoms in Diarrhea-predominant Irritable Bowel Syndrome by Increasing Hypoxanthine Biosynthesis
EARLY_Phase 1 · 2 location(s) · Jinling Hospital, China · NCT06612411Gelsectan® in the Treatment of Patients With Diarrhoea-predominant Irritable Bowel Syndrome
NA · 12 location(s) · Devintec Sagl · NCT06681012The Safety And Efficacy Of A Probiotic Intervention On Lactulose Hydrogen Breath Test-Positive Patients And Related Gast
NA · 1 location(s) · Nimble Science Ltd. · NCT06317441Combined Lactulose H2-breath Test With Abdominal Imaging
Phase N/A · 1 location(s) · Klinik Arlesheim · NCT07145580A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome
Phase 2 · 110 location(s) · GlaxoSmithKline · NCT07519395Effects of the Multispecies Probiotic Ecologic Barrier in IBS Patients With Upper GI Symptoms and Anxiety, Depression, o
NA · 1 location(s) · Institute of Gastroenterology and Hepatology, Vietnam · NCT07656623A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Diarrhea (IBS-D)
Phase 2 · 89 location(s) · Eli Lilly and Company · NCT07545759Evaluation of the Efficacy and Safety of Gelsectan in the Treatment of Diarrhea-predominant Irritable Bowel Syndrome
NA · 1 location(s) · University Medical Center Ho Chi Minh City (UMC) · NCT07000383Repeated Transcranial Magnetic Stimulation for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome: A Randomi
NA · 1 location(s) · The First Affiliated Hospital of Soochow University · NCT07581756Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children
Phase 2 · 46 location(s) · AbbVie · NCT03339128Efficacy of Rifaximin With NAC in IBS-D
Phase 2 · 1 location(s) · Mark Pimentel, MD · NCT06727422Novel Pilot Study to Treat Symptoms of IBS With Diarrhea Using Combination Therapy of a Low-FODMAP Diet and a Neuromodul
EARLY_Phase 1 · 1 location(s) · Mayo Clinic · NCT06684470Efficacy of Repeated Transcranial Magnetic Stimulation Combined With a Live Probiotic Tablet (Combined Bifidobacterium,
Phase 1 · 1 location(s) · The First Affiliated Hospital of Soochow University · NCT06960369A Study to Evaluate the Efficacy and Safety of Live SK08 Powder in Patients With IBS-D
Phase 3 · 2 location(s) · Guangzhou Zhiyi Biotechnology Co., Ltd. · NCT06247046Fecal Microbiota Transplantation for IBS
Phase 2 · 1 location(s) · Madhusudan (Madhu) Grover, MBBS · NCT05776914Lf-rTMS Attenuates Visceral Pain in Irritable Bowel Syndrome With Diarrhea
NA · 1 location(s) · The First Affiliated Hospital of Soochow University · NCT06757491
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.